Glycogen synthase kinase 3 beta (GSK3B) antibody lowers blood pressure in animals. |
![]() |
MarketWire: DiaMedica (TSX VENTURE:DMA) today announces antihypertensive results with its lead monoclonal antibody DM-204. Consistent and significant blood pressure lowering results are observed with DM-204 in all animals and the lower blood pressure occurred for the duration of the study performed. |